| answer text |
<p>NHS England holds data in relation to the number of people starting definitive
cancer treatment in each year from 2010. This includes people who have received their
first cancer treatment in that year, which includes all types of cancer treatment
and not just oncological treatments (chemotherapy and radiotherapy).</p><p> </p><p>The
number of people receiving their first treatment for cancer each year has risen significantly
each year since 2010. It should be noted that the 2018 data is published but includes
three months of provisional data, so could be subject to slight adjustment.</p><table><tbody><tr><td><p>Year</p></td><td><p>Patients
receiving first treatment</p></td></tr><tr><td><p>2010</p></td><td><p>242,396</p></td></tr><tr><td><p>2011</p></td><td><p>252,483</p></td></tr><tr><td><p>2012</p></td><td><p>259,853</p></td></tr><tr><td><p>2013</p></td><td><p>264,437</p></td></tr><tr><td><p>2014</p></td><td><p>271,662</p></td></tr><tr><td><p>2015</p></td><td><p>279,887</p></td></tr><tr><td><p>2016</p></td><td><p>285,894</p></td></tr><tr><td><p>2017</p></td><td><p>295,133</p></td></tr><tr><td><p>2018</p></td><td><p>308,058</p></td></tr><tr><td><p>Total</p></td><td><p>2,459,803</p></td></tr></tbody></table><p>
</p><p>NHS England holds data in relation to specialised commissioning spend that
will contribute to the overall spend, from 2013/14 onwards. The financial values have
been consolidated through the use of NPoC (National Programme of Care) codes and are
taken from our annual spend analysis exercise. This exercise uses Provider Aggregate
Contract Monitoring as the basis for the data; where this data is incomplete hubs
will apportion / estimate any missing values. The costs for chemotherapy and specialised
cancer surgery have been combined for 2013/14 and 2014/15.</p><table><tbody><tr><td><p>
</p></td><td><p>2013/14</p></td><td><p>2014/15</p></td><td><p>2015/16</p></td><td><p>2016/17</p></td><td><p>2017/18</p></td></tr><tr><td><p>NPoC</p></td><td><p>£
million</p></td><td><p>£ million</p></td><td><p>£ million</p></td><td><p>£ million</p></td><td><p>£
million</p></td></tr><tr><td><p>B01 - Radiotherapy</p></td><td><p>340.2</p></td><td><p>315.2</p></td><td><p>368.5</p></td><td><p>425.0</p></td><td><p>390.9</p></td></tr><tr><td><p>B02
- Chemotherapy</p></td><td rowspan="2"><p>1,730.8</p></td><td rowspan="2"><p>2,305.9</p></td><td><p>1,417.1</p></td><td><p>1,858.3</p></td><td><p>2,014.8</p></td></tr><tr><td><p>B03
- Specialised cancer surgery</p></td><td><p>1,071.3</p></td><td><p>806.3</p></td><td><p>1,240.5</p></td></tr><tr><td><p>B04
- Specialised cancer diagnostics</p></td><td><p>56.3</p></td><td><p>66.3</p></td><td><p>78.3</p></td><td><p>78.1</p></td><td><p>98.2</p></td></tr><tr><td><p>B05
- Children and young adult cancer services</p></td><td><p>79.9</p></td><td><p>94.0</p></td><td><p>121.9</p></td><td><p>124.1</p></td><td><p>178.8</p></td></tr><tr><td><p>Total</p></td><td><p>2,207.2</p></td><td><p>2,781.4</p></td><td><p>3,057.1</p></td><td><p>3,291.8</p></td><td><p>3,923.1</p></td></tr></tbody></table><p>
</p><p>Additionally, as a further indication toward total spend, NHS Improvement estimates
the total cost to National Health Service trusts and NHS foundation trusts for providing
oncological treatment as follows.</p><table><tbody><tr><td><p>Year</p></td><td><p>Estimated
total cost (£ million)</p></td></tr><tr><td><p>2010-11</p></td><td><p>£1,801</p></td></tr><tr><td><p>2011-12</p></td><td><p>£2,051</p></td></tr><tr><td><p>2012-13</p></td><td><p>£2,259</p></td></tr><tr><td><p>2013-14</p></td><td><p>£2,457</p></td></tr><tr><td><p>2014-15</p></td><td><p>£2,706</p></td></tr><tr><td><p>2015-16</p></td><td><p>£2,864</p></td></tr><tr><td><p>2016-17</p></td><td><p>£2,955</p></td></tr><tr><td><p>2017-18</p></td><td><p>£3,224</p></td></tr></tbody></table><p>
</p><p>The data source for the table is from reference costs, which are the average
unit costs to NHS trusts and NHS foundation trusts of providing defined services in
a given financial year to NHS patients. Cost data provided includes:</p><p>- Those
that relate to the following treatment function code (TFC):</p><p>- 260 - Paediatric
medical oncology</p><p>- 370 - Medical oncology</p><p>- 503 - Gynaecological oncology</p><p>-
800 - Clinical oncology (previously radiotherapy);</p><p> </p><p>- Cancer multi-disciplinary
team meetings;</p><p>- Chemotherapy and radiotherapy services; and</p><p>- Cancer
related community health services.</p><p>This may not cover all costs associated with
oncology. There are areas related to oncology where the costs cannot be identified.
These would include:</p><p>- Homecare drugs;</p><p>- Diagnostic imaging; and</p><p>-
Other cancer related health resource groups (HRGs) in other TFCs.</p><p> </p><p>There
are no primary care costs included within the data.</p><p>Data on the number of IT
systems used within oncology treatment in the NHS is not available.</p>
|
|
